about
When size matters: changing opinion in the management of pleural space-the rise of small-bore pleural cathetersPrimary lung tumors invading the chest wallThe Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma.KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer.Outcome and prognostic factors in bronchial carcinoids: a single-center experience.Thymic neuroendocrine tumors.Efficacy and safety of human fibrinogen-thrombin patch (Tachosil(®)) in the management of diffuse bleeding after chest wall and spinal surgical resection for aggressive thoracic neoplasmsMultidisciplinary management of advanced lung neuroendocrine tumors.Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer.Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project.Management of bronchial carcinoids: international practice survey among the European Society of Thoracic Surgeons.Errors and Complications in Chest Tube Placement.Management of Chest Drains After Thoracic Resections.Digital versus traditional air leak evaluation after elective pulmonary resection: a prospective and comparative mono-institutional study.Surgery of colorectal cancer lung metastases: analysis of survival, recurrence and re-surgery.Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest Group.Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal Cancer.Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group.Multimodality therapy for locally-advanced thymic epithelial tumors: where are we now?Does the World Health Organization histological classification predict outcomes after thymomectomy? Results of a multicentre study on 750 patients.Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†.Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases.Improvement in TNM staging of pulmonary neuroendocrine tumors requires histology and regrouping of tumor size.Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids.Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience.Extended transcervical thymectomy with partial upper sternotomy: results in non-thymomatous patients with myasthenia gravis.Neuroendocrine tumors of the thymus.Unless I see, I will not believe.Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer.Locally advanced non-small cell lung cancer treatment: another step forward.Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma.Basophil Membrane Expression of Epithelial Cytokine Receptors in Patients with Severe Asthma.Does myasthenia gravis influence overall survival and cumulative incidence of recurrence in thymoma patients? A Retrospective clinicopathological multicentre analysis on 797 patients.Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis.Optimal surgical approach to thymic malignancies: New trends challenging old dogmas.Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.Does perioperative chemotherapy improve survival in patients with resectable lung metastases of colorectal cancer?
P50
Q26738595-EC07410D-D262-4079-B64D-1C76B8A781B1Q28066496-749F0505-4764-4BF2-85AC-FE2E421FDC53Q35885771-4C903B17-4333-4732-A45C-EB4347E2E214Q37208731-CB841F73-075B-4DF5-991A-76CC2BBD9F0EQ37709323-0F80E12E-9F16-4231-9445-8A0537BD9E91Q38181302-DE2CD68B-0729-47B9-9D8F-571CA0A7D8B1Q38234390-DCF83553-71B1-4E80-9250-B0DF84AFA54AQ38254665-868F0234-3D93-4ADE-A85A-36D143D7B526Q38487554-16581532-74B4-4DE1-9C4F-952FDFDCE2EBQ38651094-F3EA1D2B-E86F-43E6-AA21-1C2103F8B503Q38816739-3018D6C6-D372-48CF-A156-C015E9305F91Q38853213-77A633DE-54D7-4344-89A6-444C99430EB8Q39014118-F233B067-50D7-48CB-82AA-68EB523BF2B4Q39014122-9D05E295-84A1-48EB-8CFB-1AB8BDF2B110Q40334561-9C9A4BD6-7FB9-4287-851C-E52F56F65D50Q40631680-6216498C-BFE2-4145-BFA1-F919AAE39B8AQ40824315-108C2984-0F15-430D-A00D-D71D2251E0A7Q40896672-4B311722-1D2C-4DDD-8832-BDC6190CD0BCQ41010403-74651591-9500-4C17-82C3-5C0F59BFFE34Q41616664-2B1B4C88-C075-41E2-BECB-C0C7BEBA7EC0Q42211809-346F3361-9DF2-40C1-9FC7-87AA477EA157Q42684598-3C3F734B-0E45-4013-BF7B-094D567AF0EEQ42692908-50205EB8-314F-4505-9822-6F6580437A1CQ44558782-5C3D0A3A-B509-4F33-9281-1871B9B9A691Q45069447-3BE838EC-5322-49EA-A3EA-29972F7210ACQ45353013-39574B05-E2DE-42DE-BDD4-5CC48739DF81Q45923240-603F7D08-71E0-4FEC-A994-2891D6EB7E5FQ46180671-A9303B13-B716-49E6-8E32-3F08A55CFE02Q47101499-71C657D1-6476-4C15-AC35-23B50D65E82AQ47141436-330CD9A0-EEEB-4F9F-A803-359695070BF6Q48557157-3A5C472C-D8D5-4D1F-A591-F6E5C5A3DED7Q49413036-046DCE2B-08EB-4E7F-AF0F-0C2FB56C1235Q49835207-15CC95A2-DD46-4217-8FB1-5AB46EF10920Q50057808-EB968E58-843F-42E2-AB7B-2E1E732A0111Q50198371-5FB3725C-98CE-4376-92DA-5DDD55EE0548Q51039193-EBEA7FB3-85D1-4281-86AB-F611BC950F58Q51122512-5B5D9403-F6F7-481E-B122-CE63A6AD877DQ52639680-97B70C7F-9A85-44A1-9CFD-B9D4CDD93A32Q52838432-478B7FA7-A19D-46A7-A347-5CA89F541B53Q52875215-17EE8314-8327-4B17-8A60-CE495C03D624
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesco Guerrera
@ast
Francesco Guerrera
@en
Francesco Guerrera
@es
Francesco Guerrera
@nl
Francesco Guerrera
@sl
type
label
Francesco Guerrera
@ast
Francesco Guerrera
@en
Francesco Guerrera
@es
Francesco Guerrera
@nl
Francesco Guerrera
@sl
prefLabel
Francesco Guerrera
@ast
Francesco Guerrera
@en
Francesco Guerrera
@es
Francesco Guerrera
@nl
Francesco Guerrera
@sl
P106
P1153
55968441300
P21
P31
P496
0000-0002-4125-4379